Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
about
Coming of age: the artificial pancreas for type 1 diabetesPathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxPancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the BlockAvoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseGrowth Hormone-Releasing Hormone in DiabetesClinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patientsObesity: Current and potential pharmacotherapeutics and targets.Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.Ghrelin: much more than a hunger hormone.The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attackThe search for the mechanism of early sympathetic islet neuropathy in autoimmune diabetesEffect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Biochemical stabilization of glucagon at alkaline pH.Dipeptidyl peptidase-4 inhibitor (vildagliptin) improves glycemic control after meal tolerance test by suppressing glucagon releaseResting metabolic rate in obese diabetic and obese non-diabetic subjects and its relation to glycaemic controlThe Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity.Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.A computational systems analysis of factors regulating α cell glucagon secretion.Retinoic acid-related orphan receptors α and γ: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivityDefective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cellsCoadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemiaAdrenaline: insights into its metabolic roles in hypoglycaemia and diabetesLack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetesCurrent insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.Oxyntomodulin increases intrinsic heart rate through the glucagon receptor.Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitusHypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.Sensitive glucagon quantification by immunochemical and LC-MS/MS methods.Sulfonylureas: a new look at old therapy.Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.cAMP signalling in insulin and glucagon secretion.Oral Insulin Delivery in a Physiologic Context: Review.GLP-1/glucagon receptor co-agonism for treatment of obesity.
P2860
Q26745886-806F54E3-8DCE-49F2-BEF2-DEE74BEA6AD1Q26820876-F5FC83AA-9B6E-4A7B-9A97-50B1CDE57903Q26825393-025D2A8D-B5FE-4008-9282-DB4C840108C6Q26827955-42ADB337-438A-49DC-81C7-A7C349580F48Q27027920-B097798C-134E-475A-9459-A41C321465D8Q28070104-DC0DDB65-D016-461F-85EB-A03BBF9B6D34Q28083144-E38FB822-9A55-4CBB-90A6-D2F7CBF4652EQ30243992-515228B0-F833-40CD-9247-8AE741BAB929Q30370086-1220388D-5C19-449B-BD71-CA78754D16C6Q33725885-1598B44A-5231-4855-97D3-61D419B58338Q33789390-9EFEBDA7-B40F-4455-8659-5FDECCEC3C33Q34157993-6B4A7897-6E34-4DCB-B955-7C75DDF44FD9Q34158496-70C62664-5790-43E4-B609-5E77D707CF9DQ34360882-CB01213C-80D9-4F98-AAF8-9A75113FA472Q34727768-5B3F3F58-F691-4C00-8F3B-CA26DCE04BD8Q35000090-46E56F4A-2DEF-490E-8EEF-915EBDEEA7EDQ35663711-A01D6E0F-D17D-401F-BC4B-8DE364BEBC04Q35830434-EED2DCF6-FE91-4806-9107-E39852BE2034Q35916821-A8F8E905-F6BA-4B8E-8AFB-953967790F1EQ36061147-2E579E4D-8C90-4F98-B537-AC91F4699CF7Q36394674-78881C85-D0CA-4500-ACC1-D03E5AC2E457Q36562670-C7356F5F-2CD4-439C-AE3A-F444ACD21DEFQ36597980-FEF77D99-E1A2-4588-81EC-B0EDDCEF307FQ36699681-9983DEF3-D6DF-477A-ACE8-00ACC2B13A25Q36720596-FA0E05EE-5E37-4925-9EB0-F79C9F0A9368Q36797394-276D8628-4E4E-4CBC-B6DF-73965F1591BFQ36868102-E9900949-8B4F-440B-8671-49FA68246C78Q37260041-5AC5B423-ECCE-47E6-8F41-83C148C97304Q37344159-848919DD-13CB-42D0-B990-A91B1ECE4625Q37381456-F54035AD-1787-4D89-B7F6-5C5DAE4C80F3Q38126386-B3C15BED-EBEA-49D2-BB8E-0518DF3475E5Q38167833-C74C8E19-FBB2-49F9-ADB6-0BEF8C2D1D08Q38190489-E8F33C3B-7674-4521-8878-C8A41993638AQ38203645-9E0405D8-D8CD-4F2D-9B46-1F289C61CA59Q38297682-B4DC5B24-7009-495F-9219-DC5D78BDE1A6Q38651610-33B63AAD-36E7-48B2-B31B-82996E6EB00DQ38798115-DEF23636-AEB9-4D59-97B3-FC1E920174F4Q39280145-B40EE14B-0C5D-47D5-AB42-B6F051E03243Q39400642-F14C059E-447F-499E-98DB-A384F2EA07D4Q39451553-270AF74C-0390-4903-9DE7-9A96A98CA8A0
P2860
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@ast
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@en
type
label
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@ast
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@en
prefLabel
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@ast
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@en
P2860
P921
P356
P1433
P1476
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
@en
P2093
Philip E Cryer
P2860
P304
P356
10.1210/EN.2011-1499
P407
P577
2011-12-13T00:00:00Z